Skip to Main Content

Paper Details

Nasal administration of anti-CD3 mAb (Foralumab) downregulates <i>NKG7</i> and increases <i>TGFB1</i> and <i>GIMAP7</i> expression in T cells in subjects with COVID-19.
Proc Natl Acad Sci U S A
5
2023
B cells, C-reactive protein, COVID-19, Foralumab, GTP, GTP-binding gene, GTPases, MS, NGK7, NGK7 effector T cells, RNA, ROCK1, Rho, SARS-CoV-2, T cells, anti-CD3, anti-CD3 mAb, cell types, human, lung inflammation, mice, monocytes, nave-like T cells, patients, serum IL-6, severe acute respiratory syndrome coronavirus 2
Author NameAffiliation
Saef IzzyAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School
Clare Baecher-AllanAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School
Howard L WeinerAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School
  • 1 - 3

Datasets

Release 1.2